Gene Score, Endocrine Response Can Guide Early Breast Cancer Therapy
Use of the 21-gene recurrence score (RS) combined with response to 3-week preoperative endocrine therapy can be used to guide systemic therapy in early breast cancer patients with limited nodal involvement, and can help avoid overtreatment with chemotherapy, according to German investigators. Among patients with early, hormone receptor (HR)-positive/HER2-negative breast cancer, the 5-year invasive disease-free …
Gene Score, Endocrine Response Can Guide Early Breast Cancer Therapy Read More »